Tillman Cardinal
Tillman Cardinal
Tillman is a co-founder and Managing Partner of Basis Ventures.
He is a seasoned veteran of venture capital with almost 20 years experience in high-tech investing. Prior to Basis Ventures, Tillman spent eight years as a general partner with Kirchner Perry.
Before Kircher Perry, Tillman ran the Nuclear Medicine Division of Omia Healthcare, which he grew to a multi-hundred million-dollar business unit.
Tillman’s investment focus is in the life sciences area. He is currently on the board of directors of Kado Labs, Edgemix Devices, Cogindu Biotech and Olith Probes.
He has a B.A. from the University of California, Los Angeles and an M.B.A. from The Kellogg School of Management.